Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Robotic Endoluminal Surgery Market Set To Climb From $1.71 Billion In 2026 To $3.33 Billion By 2030
The robotic endoluminal surgery market has witnessed rapid growth in recent years. It is anticipated to increase from $1.45 billion in 2025 to $1.71 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 18.4%. The expansion observed in the past can be ascribed to several factors, including the rising demand for minimally invasive procedures, the increased adoption of endoscopic technologies, a growing preference for shorter hospital stays, the expanding application of robotic-assisted surgeries, and the need for greater precision in hard-to-reach anatomies.
The robotic endoluminal surgery market is projected to experience swift expansion over the coming years. This market is predicted to reach $3.33 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This anticipated growth during the forecast timeframe is attributable to increased capital allocated to surgical robotics investigations, the deepening incorporation of AI and machine learning into surgical platforms, the expanding market presence of flexible robotic apparatus, a broader spectrum of clinical uses in gastrointestinal and vascular interventions, and patients’ increasing desire for quicker convalescence and less invasive treatment. Key developments expected within this period encompass technological enhancements in adaptable robotic endoscopes, novelties in capsule and micro-robotic instruments, progress in AI-powered navigation technologies, ongoing research and development efforts in self-operating robotic surgery, and improvements in live imaging and robotic visual feedback systems.
Get A Free Sample Report With In-Depth Market Insights:
Robotic Endoluminal Surgery Market Growth Factors Behind Sustained Expansion
The robotic endoluminal surgery market is anticipated to expand due to the growing embrace of minimally invasive surgical techniques. These procedures involve operations through small incisions or a single entry point, which lessens patient trauma, shortens recovery periods, and reduces complication risks. The increased preference for minimally invasive surgeries stems from hospitals and patients prioritizing quicker recovery, less post-operative pain, lower chances of complications, and minimal scarring compared to traditional open operations. Robotic endoluminal surgery plays a crucial role in these procedures by facilitating precise navigation and manipulation within internal lumens, such as the gastrointestinal or respiratory tracts, thereby improving patient outcomes through reduced tissue trauma, faster recovery, and enhanced procedural accuracy. For example, Intuitive Surgical Inc., a US-based medical technology firm, reported in January 2025 that worldwide da Vinci procedures, a form of minimally invasive robotic-assisted surgery, saw an approximate growth of 18% in the fourth quarter of 2024 compared to the fourth quarter of 2023. Furthermore, full year 2024 procedures increased by approximately 17% relative to 2023, with the company forecasting a 13% to 16% rise in worldwide da Vinci procedures for 2025 compared to 2024. Consequently, the rising adoption of minimally invasive and single-port surgeries is a key factor propelling the expansion of the robotic endoluminal surgery market.
Robotic Endoluminal Surgery Market Breakdown By Product Type And Application
The robotic endoluminal surgery market covered in this report is segmented –
1) By Product Type: Surgical Systems, Accessories And Instruments, Services
2) By Application: Gastrointestinal Surgery, Urological Surgery, Pulmonary Surgery, Gynecological Surgery, Others
3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others
Subsegments:
1) By Surgical Systems: Flexible Endoscopic Robots, Bronchoscopy Robots, Gastrointestinal Navigation Robots, Colorectal Endoluminal Robots, Esophageal Endoscopic Robots
2) By Accessories And Instruments: Robotic Endoscopic Tools, Robotic Catheters, Robotic Endoscopic Cameras, Robotic Biopsy Devices, Robotic Graspers And Scissors
3) By Services: Installation And Integration Services, Maintenance And Repair Services, Training And Education Services, Software Upgrade Services, Technical Support Services
Robotic Endoluminal Surgery Market Industry Trends Fueling Future Revenue Growth
Leading companies in the robotic endoluminal surgery market are concentrating on developing advanced technologies, such as integrated artificial intelligence and real-time imaging systems, with the goal of increasing procedural accuracy, elevating patient safety, and enhancing diagnostic efficiency. These integrated AI and advanced imaging systems denote software enhancements that combine machine learning with live procedure data to assist physicians in navigating complex anatomy and locating tissue targets with greater precision. For example, in October 2025, Intuitive Surgical Inc., a US-based medical technology company, obtained U.S. Food & Drug Administration (FDA) clearance for software advancements intended for its Ion endoluminal system. The approved innovations encompass improved 3D visualization of the lung airway tree and the incorporation of AI-based imaging functionality, which assists in identifying suspicious lung lesions during biopsy procedures. This integration is designed to offer more intuitive navigation and information, thereby supporting physician decision-making for more precise tissue sampling. Its objective is to boost the system’s utility in the early diagnosis of lung cancer, potentially leading to improved patient outcomes.
Robotic Endoluminal Surgery Market Competitive Overview And Top Companies
Major companies operating in the robotic endoluminal surgery market are Medtronic plc, Fujifilm Holdings Corporation, Intuitive Surgical Inc., Olympus Corporation, CMR Surgical Ltd., Noah Medical Inc., Distalmotion SA, Ronovo Surgical Inc., Stereotaxis Inc., Neocis Inc., MicroPort MedBot Co. Ltd., Virtual Incision Corporation, Asensus Surgical Inc., EndoQuest Robotics Inc., SS Innovations International Inc., Edge Medical Robotics, Moon Surgical, Robocath SAS, SurgEase Innovations, EndoTools Therapeutics SA, Microbot Medical Inc.
View The Full Robotic Endoluminal Surgery Market Report:
Robotic Endoluminal Surgery Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the robotic endoluminal surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic endoluminal surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
